FactaeThe Factual News

BIOPHYTIS has 18 months of cash for its Phase 2 clinical trial

BIOPHYTIS reports having 18 months of cash to conduct its Phase 2 clinical trial.

Published 2h1 source

Lire en français

≈ 18sSpeed

The fact

This financial situation allows the company to continue its therapeutic trials.

Investors are closely monitoring the next steps in development.

Click the link to read an article on the topic:

Explore this topic

France BIOPHYTIS #BIOPHYTIS #trésorerie #phase 2 #essais cliniques #biotech #marché boursier #investisseurs

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.

France · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on September 15, 2026

← Back to home

Discover

Read more

All marches →